Raj Prabhakar
Corporate Officer/Principal presso ROCKET PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Raj Prabhakar is currently the Chief Business Officer & Senior Vice President at Rocket Pharmaceuticals, Inc. Prior to his current position, he held the role of Executive Director-Business Development at Imunon, Inc. from 2004 to 2015.
Following that, he served as the Senior Vice President-Business Development at Caladrius Biosciences, Inc. from 2015 to 2017.
Mr. Prabhakar completed his undergraduate studies at Massachusetts Institute of Technology and holds an MBA from Harvard Business School.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
24/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Raj Prabhakar
Società | Posizione | Inizio |
---|---|---|
ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2017 |
Precedenti posizioni note di Raj Prabhakar
Società | Posizione | Fine |
---|---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 01/10/2017 |
IMUNON, INC. | Corporate Officer/Principal | 01/07/2015 |
Formazione di Raj Prabhakar
Massachusetts Institute of Technology | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
IMUNON, INC. | Health Technology |
ROCKET PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 1 |
---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
- Borsa valori
- Insiders
- Raj Prabhakar